Medical Health & Life Science Research News

Blood screening market to extent $ 2.80 billion by 2021 according to new research report

Blood screening market to extent $ 2.80 billion by 2021 according to new research report

The global blood screening market is categorized based on technology, product & service, end-user, and region. The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%.

- Agency -.

In blood screening market NAT segment is expected to grow at the highest CAGR during the forecast period. Major factors contributing to the growth in this segment are increasing number of blood donations, rising incidence of various infectious diseases, and increasing disposable income to pay for advanced blood screening procedures including NAT-test.

Complete Report on Blood Screening Market spread across 150 Pages, Profiling 11 Companies and Supported with 97 Tables and 39 Figures is now available at www.rnrmarketresearch.com/blood-sc…arket-report.html .

Blood screening market segmented into reagents & kits, instruments, and software & services.

- Agency -.

In 2016, the reagents and kits segment is expected to account for the largest share of the market.

The repeated usage of reagents and kits is the key driving factor driving the growth of this segment. On the basis of end user, the market is segmented into blood banks and hospitals.

In 2016, the blood banks segment is expected to account for the largest of the market.

 

Stockholder of blood screening market report:

  • Blood Screening Instruments and Reagents Manufacturers
  • Blood Screening Software and Services Providers
  • Blood Banks
  • Hospitals
  • Red Cross Societies
  • Regulatory Bodies
  • Research and Consulting Firms
  • Government Bodies

Geographically, blood screening market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth of this market can be attributed to increasing adoption of nucleic acid tests (NAT) in this region.

In addition, increasing participation of various government associations in blood donations and screening & transfusion activities also supports growth of North American blood screening market.

Click Now for PDF Sample Download of this Study Report

www.rnrmarketresearch.com/contacts…mple?rname=310626 .

Globally, blood screening market witnessing substantial growth due to factors like increasing number of blood donations & blood donors, growing affordability & adoption of nucleic acid test (NAT) for blood screening, rising awareness regarding safety of donated blood, growing demand for donated blood, and increasing prevalence/incidence of infectious diseases.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.

  • By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
  • By Designation: Director Level: 58%, C-level: 25%, Others: 17%
  • By Region: North America: 46%, Europe: 31%, APAC: 15%, RoW: 8%

Major players in blood screening market include Grifols (Spain), Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Ortho Clinical Diagnostics, Inc. (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), bioMérieux (France),Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).

Connect for More Details for More Information “Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021” report @ www.rnrmarketresearch.com/contacts…ount?rname=310626 .

Blood screening market is driving growth are increasing number of blood donations and blood donors and rising awareness regarding safety of donated blood. In addition, increasing affordability and adoption of nucleic acid test (NAT) for blood screening, rising demand for donated blood, and increasing prevalence of infectious diseases are also driving growth of this market.

However, capital expenditure and the operating costs of NAT instruments, lack of mandates for NAT in developing countries, and emergence of alternative technologies are restraining market growth.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.